Dong-A ST Faces New Wave Of Change As It Challenges Norms

Park Looks To Shake Up 'Outdated' R&D Approaches

 
• By Jung Won Shin
  
Jae-Hong Park, President, CSO of Dong-A ST
Dong-A's R&D Focus is On Oncology, Inflammation • Source: Dong-A ST
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia